Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2010
12/14/2010CA2287520C Enzymatic dna molecules
12/14/2010CA2267893C Method and potentiated composition for treating migraine
12/14/2010CA2247989C C-c ckr-5,cc-chemokines receptor, derivatives thereof and their uses
12/14/2010CA2233316C Methods for enhanced virus-mediated dna transfer using molecules with virus- and cell-binding domains
12/14/2010CA2211427C Dna molecules, preparation thereof and use thereof in gene therapy
12/14/2010CA2159546C Cycloalkano-indole and -azaindole derivatives
12/09/2010WO2010141956A2 Methods and compositions for the treatment of cancer
12/09/2010WO2010141949A2 Urea sorbent
12/09/2010WO2010141932A1 Aminopyrrolidinone derivatives and uses thereof
12/09/2010WO2010141861A1 Synthetic glucopyranosyl lipid adjuvants
12/09/2010WO2010141842A2 Interlaced method for treating cancer or a precancerous condition
12/09/2010WO2010141834A1 Ophthalmic formulations of fluticasone and methods of use
12/09/2010WO2010141824A2 Use of targeted nitroxide agents in bone healing
12/09/2010WO2010141817A1 Heteroaryl-substituted spirocyclic diamine urea modulators of fatty acid amide hydrolase
12/09/2010WO2010141810A2 Compositions and methods modulating mg29 for the treatment of diabetes
12/09/2010WO2010141809A1 Aryl-substituted heterocyclic urea modulators of fatty acid amide hydrolase
12/09/2010WO2010141805A1 Heterocyclic amides as modulators of trpa1
12/09/2010WO2010141771A1 Nucleic acid modulators of glycoprotein vi
12/09/2010WO2010141768A2 Polycyclic antagonists of lysophosphatidic acid receptors
12/09/2010WO2010141761A2 Polycyclic antagonists of lysophosphatidic acid receptors
12/09/2010WO2010141738A2 Compositions and method for inhibiting tumor growth
12/09/2010WO2010141712A2 Modulation of kcnq potassium channel activity for treatment of psychiatric disorders and the symptoms thereof
12/09/2010WO2010141711A1 Skin treatment compositions
12/09/2010WO2010141690A2 Indane analogs and use as pharmaceutical agents and process of making
12/09/2010WO2010141688A1 Inhibition of bacteria through application of a diluted solution of a silicate chemical
12/09/2010WO2010141680A2 Hedgehog pathway antagonists and methods of use
12/09/2010WO2010141666A2 Modulating endogenous beta-endorphin levels
12/09/2010WO2010141630A1 Compositions and methods for treatment of cancer by disrupting the lh/lhr signaling pathway
12/09/2010WO2010141609A1 Use of angiotensin converting enzyme (ace) domain specific inhibitors to inhibit or enhance cytokine production and alter immune response
12/09/2010WO2010141600A2 Improved method for synthesizing pirfenidone
12/09/2010WO2010141592A2 Chemical fragment screening and assembly utilizing common chemistry for nmr probe introduction and fragment linkage
12/09/2010WO2010141588A1 Ophthalmic oil-in-water emulsions containing cyclosporine or a polyphenol
12/09/2010WO2010141584A2 Antagonism of human formyl peptide receptor for treatment of disease
12/09/2010WO2010141525A1 Active metabolite of a thrombin receptor antagonist
12/09/2010WO2010141511A2 Polynucleotides for multivalent rna interference, compositions and methods of use thereof
12/09/2010WO2010141505A1 Abuse-resistant delivery systems
12/09/2010WO2010141494A2 Synthesis of ezetimibe
12/09/2010WO2010141471A2 Nucleic acid delivery compositions and methods of use thereof
12/09/2010WO2010141427A1 Treatment of ophthalmologic disorders mediated by albha-carbonic anhydrase isoforms
12/09/2010WO2010141424A1 Carbamate and urea inhibitors of 11beta-hydroxysteroid dehydrogenase 1
12/09/2010WO2010141406A2 Amino pyrimidine anticancer compounds
12/09/2010WO2010141330A1 DERIVATIVES OF 6,7-DIHYDRO-5H-IMIDAZO[1,2-a]IMIDAZOLE-3-CARBOXYLIC ACID AMIDES
12/09/2010WO2010141273A1 DERIVATIVES OF 6,7-DIHYDRO-5H-IMIDAZO[1,2-a]IMIDAZOLE-3-CARBOXYLIC ACID AMIDES
12/09/2010WO2010141247A1 Hexahydrocyclopentyl[∫]indazole 5-hydroxymethyl ethanols and derivatives thereof as selective glucocorticoid receptor modulators
12/09/2010WO2010141191A1 Method to stabilize a dietary supplement comprising glucosamine
12/09/2010WO2010141074A2 O-glcnac transferase inhibitors and uses thereof
12/09/2010WO2010141069A2 Pure peg-lipid conjugates
12/09/2010WO2010140992A1 Stable pharmaceutical compositions containing rosuvastatin calcium
12/09/2010WO2010140986A1 Targetted drug delivery to the bone
12/09/2010WO2010140902A1 Inhibitors of macrophage migration inhibitory factor
12/09/2010WO2010140869A2 Complex, multilayer using the same, and device coated with the multilayer
12/09/2010WO2010140765A2 Novel method for preparing rosuvastatin, intermediate compounds useful for preparing same, and method for preparing same
12/09/2010WO2010140716A1 Composition and alcoholic beverage for relieving hangovers and including ornithine or an ornithine salt
12/09/2010WO2010140694A1 Method for screening of inhibitor using factor capable of enhancing production of amyloid-beta peptide, and inhibitor obtained by same
12/09/2010WO2010140686A1 Emulsifying preparation
12/09/2010WO2010140685A1 Heterocyclic compound and hematopoietic stem cell amplifier
12/09/2010WO2010140409A1 Neurite elongation agent, memory-improving agent and anti-alzheimer agent comprising 4'-demethylnobiletin or 4'-demethyltangeretin as active ingredient, and process for production of the compound
12/09/2010WO2010140339A1 Heterocyclic compound
12/09/2010WO2010140271A1 Substance having relaxing activity, concentration-enhancing activity and anti-stress activity
12/09/2010WO2010140170A1 Topical micro-emulsions for the treatment of rheumatic disorders
12/09/2010WO2010140139A2 Crystalline forms of 6- ( 1h- imidazol- 1-yl) -2-phenylquinazoline and salts thereof
12/09/2010WO2010140111A1 Pharmaceutical compositions containing a combination of an antihistamine and a decongestant
12/09/2010WO2010140092A1 L- ( piperidin-4-yl) -pyrazole derivatives as gpr 119 modulators
12/09/2010WO2010140024A1 Methods for diagnosing and treating a renal disease in an individual
12/09/2010WO2010139985A1 The use of amlexanox in the therapy of neutrophil-driven diseases
12/09/2010WO2010139982A1 Indole derivatives for the stimulation of stem cell proliferation
12/09/2010WO2010139981A2 Processes for preparing crystalline forms
12/09/2010WO2010139980A1 Process for preparing crystalline dasatinib monohydrate
12/09/2010WO2010139979A2 Processes for preparing crystalline forms
12/09/2010WO2010139967A1 Dihydroindole and tetrahydroisoquinoline derivatives useful as potassium channel inhibitors
12/09/2010WO2010139966A1 Azole derivatives as wtn pathway inhibitors
12/09/2010WO2010139954A1 Treatment of eye discomfort by topical administration of a cooling agent to the external surface of the eyelid
12/09/2010WO2010139838A1 Genetically modified non-human mammal, cells and methods for producing same
12/09/2010WO2010139827A1 Inhibitor compounds of 11-beta-hydroxysteroid dehydrogenase type 1
12/09/2010WO2010139805A1 Composition including at least one trans-cinnamaldehyde and the use thereof in the treatment of bacterial infections, specifically in the treatment of nosocomial infections
12/09/2010WO2010139784A1 Lysine-specific demethylase 1 (lsd1) is a biomarker for breast cancer
12/09/2010WO2010139758A1 Novel derivatives of aryl-{4-halogeno-4-[aminomethyl]-piperidin-1-yl}-methanone, their method of preparation and their use as medicinal products
12/09/2010WO2010139752A2 Stabilised composition comprising at least one adrenergic compound
12/09/2010WO2010139751A2 Stabilised composition comprising at least one adrenergic compound
12/09/2010WO2010139747A1 1H-IMIDAZO[4, 5-c]QUINOLINONE COMPOUNDS, USEFUL FOR THE TREATMENT OF PROLIFERATIVE DISEASES
12/09/2010WO2010139731A1 1H-IMIDAZO[4,5-c]QUINOLINONE DERIVATIVES
12/09/2010WO2010139717A1 New compounds
12/09/2010WO2010139707A1 2-aminooxazolines as taar1 ligands
12/09/2010WO2010139690A1 Bacteria thya(-) mutants with increased vitamin k
12/09/2010WO2010139678A1 Treatment of mammalian disorders mediated by alpha-carbonic anhydrase isoforms
12/09/2010WO2010139665A1 Treatment of malignant diseases
12/09/2010WO2010139660A2 Ginger compositions
12/09/2010WO2010139627A1 New compositions for treating cmt and related disorders
12/09/2010WO2010139483A1 Glycine b antagonists
12/09/2010WO2010139482A1 Glomerulonephritis treatment
12/09/2010WO2010139481A1 Glycine b antagonists
12/09/2010WO2010139411A2 17β-ALKYL-17α-OXY-ESTRATRIENES
12/09/2010WO2010139352A1 Lipopolysaccharide of ochrobactrum intermedium and their use as immunostimulant of mammalians
12/09/2010WO2010139289A1 Substituted 6-(2-hydroxybenzylamino)purine derivatives, their use as medicaments and compositions containing these derivatives
12/09/2010WO2010139288A1 5,7-disubstituted 3-isopropylpyrazolo[4,3-d]pyrimidines for use as medicaments and pharmaceutical compositions
12/09/2010WO2010139256A1 Adduct formed by phosphodiesterase inhibitor and isoflavone and use thereof
12/09/2010WO2010139253A1 Glycyrrhetinic acid ester derivative synthesis method and deoxoglycyrrhetinic acid ester compound
12/09/2010WO2010139252A1 Use of isothiocyanates for promoting growth of hairs
12/09/2010WO2010139180A1 Naphthalene carboxamide derivatives as inhibitors of protein kinase and histone deacetylase, preparation methods and uses thereof
12/09/2010WO2010139090A1 N-phenyl dichloroacetamide and their derivatives, preparation methods and uses theirof
1 ... 1963 1964 1965 1966 1967 1968 1969 1970 1971 1972 1973 1974 1975 1976 1977 1978 1979 1980 1981 1982 1983 ... 7860